Company intelligence / Profile preview
Gateway Biotechnology Inc.
Durham, North Carolina, United Statesgatewaybiotechnology.net ↗
- Ownership
- Private
- Employees
- ~1
- Development stage
- Other
01
Overview
The company has developed a novel animal screening model for tinnitus and has identified promising drug candidates (GW-TT2 and GW-TT5) for clinical studies. Their lead product is reportedly undergoing a Phase II clinical trial as part of an exclusive contract with the U.S. Army.
- Therapeutic areas
- Neurology
- Modalities
- Small moleculesDrug therapies
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
03
Partnerships
U.S. Army (exclusive contract)
Beyond the preview
Go deeper on Gateway Biotechnology Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Gateway Biotechnology Inc..